Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Salvacion Usa Inc. has one pending office action in Biotechnology & Pharmaceuticals. The matter is concentrated with HELM, CARALYNNE E, and the record identifies a single art unit. This creates a narrow prosecution profile in which the next response can be planned around one examiner’s handling of the application rather than a portfolio-wide distribution of examination responsibility.
For counsel, the immediate priority is to review the pending action against the claim language, cited references, and any stated formal requirements. Because the available record does not show multiple examiners or art units, examiner-specific practice and the art unit’s treatment of the technology may be especially useful in shaping amendments and argument. Any response should preserve commercially important biotechnology scope while addressing the issues raised in the action directly.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELM, CARALYNNE E | 1 | 28.9% | +49.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17576098 | ANTIVIRAL COMPOSITION AND USE OF THE SAME | HELM, CARALYNNE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17576098 | ANTIVIRAL COMPOSITION AND USE OF THE SAME | HELM, CARALYNNE E | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17576098 | ANTIVIRAL COMPOSITION AND USE OF THE SAME | HELM, CARALYNNE E | 1615 | §103§112Other | Non-Final OA | — | Pending | Jan 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSalvacion Usa Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Caralynne E Helm has the most, with 1 of Salvacion Usa Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.